NCT01206439View on ClinicalTrials.gov

An Advanced Echocardiographic Evaluation of Nebivolol

PHASE4TerminatedINTERVENTIONAL

Enrollment

2

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions

Hypertension

Interventions

DRUG

nebivolol

nebivolol 5 or 10 mg oral, daily

Trial Locations (1)

45267

University of Cincinnati, Cincinnati

Sponsors

Collaborators (1)

Forest Laboratories

All Listed Sponsors

collaborator

Forest Laboratories

INDUSTRY

lead

Jack Rubinstein

OTHER